New study tests if rehumanizing thoughts can reduce suicidal ideation
NCT ID NCT06713473
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study explores whether reducing feelings of being 'less than human' can lower suicidal thoughts and increase oxytocin levels. Fifty adults aged 18-40 with moderate self-dehumanization and current suicidal thoughts will be randomly assigned to a rehumanization exercise or a control group. Researchers will measure changes in suicidal ideation and blood oxytocin levels before and after the intervention.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could point toward a new psychological approach to reduce suicide risk by addressing feelings of dehumanization.
What could go wrong
This is a small, early-stage study with only 50 participants, so results may not apply broadly. It tests a brief intervention, not a treatment, and may show no significant effect.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REHUMANIZATION INTERVENTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Florida State University
Tallahassee, Florida, 32304, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••